Shares of the pharmaceutical company received a quant upgrade Monday.
These 'bearish bets' are showing both technical and quantitative deterioration.
Here's how to play the stock right now.
Breaking down an approach to the long side of this biotech stock.
Let's review the charts and indicators.
Let's see what the charts and indicators have in store.
A downgrade by TheStreet's Quant Ratings service reinforces the bear case.
It is great to see two or more investment strategies with similar conclusions.
TheStreet's quants like the stock. What do the charts say?
Let's check out the charts of VMI, which recent received a quant upgrade.